Home

Subscription

September 2017 issue

August 2017 issue

July 2017 issue

June 2017 issue

May 2017 issue

April 1, 2017 issue

March 2017 issue

February 2017 issue

January 2017 issue



BACK ISSUES

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006


2014 Issues

December 2014 Issue
• Feature - With Optimism!
• Appreciation
• New Drug Review: Dulaglutide (Trulicity - Lilly)
• Index for Volume 9, 2014


November 2014 Issue
• Feature - Serious Medication Errors Must be Reported – for Educational and Preventative Purposes!
• New Drug Review: Bazedoxifene acetate/conjugated estrogens (Duavee - Pfizer)


October 2014 Issue
• Feature - Health, Wellness, and Cigarettes
• New Drug Review: Apremilast (Otezla - Celgene)


September 2014 Issue
• Feature - Voters in North Dakota Should Oppose the Challenge to the Pharmacy Ownership Law!
• Chantix Should be Available Without a Prescription from a Pharmacist!
• New Drug Review: Empagliflozin (Jardiance - Boehringer-Ingelheim; Lilly)


August 2014 Issue
• Feature - Hydrocodone, Zohydro ER, Pain Relief, Addiction, and Death—What Are Our Priorities?
• New Drug Review: Albiglutide (Tanzeum - GlaxoSmithKline)


July 2014 Issue
• Feature - Patients Held Hostage! Exorbitant Drug Prices Will Result in Rationing of Treatment and Price Controls!
• New Drug Review: Umeclidinium bromide/vilanterol trifenatate (Anoro Ellipta - GlaxoSmithKline)


June 2014 Issue
• Feature - More than 10 Colleges of Pharmacy Will Close in the Next 20 Years! UNLESS . . . . .
• New Therapeutic Agents Marketed in the United States in 2013


May 2014 Issue
• Feature - Bigger Won't Be Better If Pfizer Acquires AstraZeneca! And Tens of Thousands Will Lose Their Jobs
• New Drug Review: Avanafil (Stendra - Auxilium; Vivus)


April 2014 Issue
• Feature - Pharmacy's National Treasure – COMMUNITY PHARMACISTS! But They are Threatened!
• New Drug Review: Dapagliflozin propanediol (Farxiga - Bristol-Myers Squibb; AstraZeneca)


March 2014 Issue
• Feature - Over-The-Counter Drug Monograph System – PAST, PRESENT AND FUTURE
• New Drug Review: Dolutegravir sodium (Tivicay - GlaxoSmithKline; ViiV)


February 2014 Issue
• Feature - Commendation for CVS!
• Commendation for the Pharmacies that Never Sold or have Discontinued the Sale of Tobacco Products!
• The Tipping Point Should Become a Domino Effect!
• Chantix Should be Available Without a Prescription from a Pharmacist!
• New Drug Review: Sofosbuvir (Sovaldi - Gilead)


January 2014 Issue
• Feature - We Will Try Resolutions Again but Pharmacy May Need a Revolution!
• New Drug Review: Vortioxetine hydrobromide (Brintellix - Lundbeck; Takeda)